Global Generic Active Pharmaceutical Ingredients Market Professional Survey Report 2019
SKU ID : QYR-14867717 | Publishing Date : 06-Nov-2019 | No. of pages : 109
The global Generic Active Pharmaceutical Ingredients market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Generic Active Pharmaceutical Ingredients volume and value at global level, regional level and company level. From a global perspective, this report represents overall Generic Active Pharmaceutical Ingredients market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Generic Active Pharmaceutical Ingredients in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Generic Active Pharmaceutical Ingredients manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Pfizer, Inc. (U.S.)
Novartis International AG (Switzerland)
Sanofi (France)
Boehringer Ingelheim (Germany)
Bristol-Myers Squibb (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Eli Lilly and Company (U.S.)
GlaxoSmithKline plc (U.K.)
Merck & Co., Inc. (U.S.)
AbbVie Inc. (U.S.)
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Monoclonal Antibodies
Hormones
Cytokines
Fusion Proteins
Therapeutic Enzymes
Vaccines
Blood Factors
Segment by Application
Oncology
Diabetes
Cardiovascular Disease
CNS and Neurological Disorders
Endocrinology
Others
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region